Cellular senescence is a complex phenomenon characterized by irreversible cell cycle arrest and the acquisition of a senescence-associated secretory phenotype (SASP). Epigenetic modifications play a crucial role in regulating cellular senescence, making them an attractive target for research and therapeutic interventions. Epigenetically induced senescence models serve as valuable tools for basic research into the molecular underpinnings of aging and have translational implications for developing interventions to enhance healthy aging and mitigate age-related diseases.
Fig. 1 Overview of the epigenetic events and effectors during cellular senescence. (Nacarelli T, et al., 2017)
CD BioSciences, a leading biotechnology company, offers a series of services for customizing epigenetically induced senescence cellular models.
Heterochromatin refers to the condensed and transcriptionally silent regions of the genome. CD BioSciences employs various techniques to modulate heterochromatin to induce senescence in target cells. We utilize advanced technologies to selectively alter DNA methylation patterns in specific genomic regions associated with senescence-related genes. Our customization services enable clients to study the effects of targeted gene silencing on cellular senescence.
Post-translational modifications of histones, such as methylation, acetylation, and phosphorylation, can influence gene expression by altering chromatin structure. We leverage various techniques to manipulate histone modifications in a precise and controlled manner, thereby inducing senescence in target cells.
Chromatin remodeling refers to the dynamic alteration of chromatin structure to regulate gene expression. CD BioSciences employs various methods, including the use of ATP-dependent chromatin remodelers and histone chaperones, to remodel chromatin and induce senescence in target cells. Our approach offers a powerful tool for investigating the epigenetic mechanisms underlying cellular senescence.
Customizing epigenetically induced senescence models involves a systematic workflow that CD BioSciences follows to ensure reliable and reproducible results. The workflow typically includes the following steps:
CD BioSciences offers abundant services for customizing epigenetically induced senescence cellular models. Leveraging our expertise, researchers can advance their understanding of senescence and contribute to the development of novel therapeutic strategies targeting aging-related diseases. If you are interested in our services, please feel free to contact us or make an online inquiry.
Reference
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.